U.S. pharmaceutical giant Pfizer (PFE) has approached British rival AstraZeneca (AZN.L) to propose a 60 billion pound ($101 billion) takeover, the Sunday Times reported on Sunday. The paper said, citing senior investment bankers and industry sources, that informal conversations about a deal had taken place between the two firms but that no talks were currently under way after AstraZeneca resisted the approach. AstraZeneca is Britain's second-biggest pharmaceuticals group with a current market valuation of arou
Pfizer is about devours yet another company to keep itself alive. Too bad for all of the AZ employees who will soon be out of work. Watch out AbbVie someone maybe coming for us.
If approved and not priced at an arm, leg AND eyeball, then The payers will kill Gilead. Those guys are dipshits.
They sold $2.27B in their new drug. I doubt they are worried about us. By the time we launch, they will have sold $12B in product. That is equal to the first 6 combined years of HUMIRA revenue in 6 months. This is not even their best option. My my my. Now, that is impressive.
True. AZ is much larger than AbbVie, but we have too much "cash" (bc of Humira revenue) to get bought out, unfortunately.
Keep on telling yourself this if it keeps you happy. Regards, The Ghosts of Wyeth, Pharmacia, Warner Lambert, Schering-Ploug, Parke-Davis and Upjohn.
